Literature DB >> 26353794

Recent advances in the understanding and management of delayed puberty.

Christina Wei1, Elizabeth Clare Crowne2.   

Abstract

Delayed puberty, especially in boys, is a common presentation in paediatrics. Recent advances have improved our understanding of the neuroendocrine, genetic and environmental factors controlling pubertal development, and hence inform the pathophysiology of delayed puberty. The discovery of kisspeptin signalling through its receptor identified neuroendocrine mechanisms controlling the gonadotrophin-releasing hormone (GnRH) pulse generator at the onset of puberty. Genetic mechanisms from single gene mutations to single nucleotide polymorphism associated with delayed puberty are being identified. Environmental factors, including nutritional factors and endocrine disruptors, have also been implicated in changes in secular trends and abnormal timing of puberty. Despite these advances, the key clinical question is to distinguish delayed puberty associated with an underlying pathology or hypogonadism from constitutional delay in growth and puberty, which remains challenging as biochemical tests are not always discriminatory. The diagnostic accuracies of newer investigations, including 36-hour luteinising hormone releasing hormone (LHRH) tests, GnRH-agonist tests, antimullerian hormone and inhibin-B, require further evaluation. Sex hormone replacement remains the main available treatment for delayed puberty, the choice of which is largely dictated by clinical practice and availability of the various sex steroid preparations. Spontaneous reversal of hypogonadism has been reported in boys with idiopathic hypogonadotrophic hypogonadism after a period of sex steroid treatment, highlighting the importance of reassessment at the end of pubertal induction. Novel therapies with a more physiological basis such as gonadotrophins or kisspeptin-agonist are being investigated for the management of hypogonadotrophic hypogonadism. Careful clinical assessment and appreciation of the normal physiology remain the key approach to patients with delayed puberty. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Adolescent Health; Endocrinology; Hypogondism; Kisspeptin, human; Puberty

Mesh:

Year:  2015        PMID: 26353794     DOI: 10.1136/archdischild-2014-307963

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

Review 1.  Effects of the Timing of Sex-Steroid Exposure in Adolescence on Adult Health Outcomes.

Authors:  Yee-Ming Chan; Amalia Feld; Elfa Jonsdottir-Lewis
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

2.  PRACTICE VARIATION IN THE MANAGEMENT OF GIRLS AND BOYS WITH DELAYED PUBERTY.

Authors:  Jia Zhu; Henry A Feldman; Erica A Eugster; Patricia Y Fechner; Leena Nahata; Paul S Thornton; Yee-Ming Chan
Journal:  Endocr Pract       Date:  2019-12-20       Impact factor: 3.443

Review 3.  Paediatric and adult-onset male hypogonadism.

Authors:  Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi
Journal:  Nat Rev Dis Primers       Date:  2019-05-30       Impact factor: 52.329

4.  Efficacy and Safety of Letrozole in the Management of Constitutional Delay in Growth and Puberty: A Systematic Review and Meta-analysis

Authors:  Deep Dutta; Rajiv Singla; Vineet Surana; Meha Sharma
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-09-03

Review 5.  Genetics of pubertal timing.

Authors:  Jia Zhu; Temitope O Kusa; Yee-Ming Chan
Journal:  Curr Opin Pediatr       Date:  2018-08       Impact factor: 2.856

6.  Serum inhibin B for differentiating between congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty: a systematic review and meta-analysis.

Authors:  Yuting Gao; Qin Du; Liyi Liu; Zhihong Liao
Journal:  Endocrine       Date:  2021-01-19       Impact factor: 3.633

7.  A synthetic kisspeptin analog that triggers ovulation and advances puberty.

Authors:  C Decourt; V Robert; K Anger; M Galibert; J-B Madinier; X Liu; H Dardente; D Lomet; A F Delmas; A Caraty; A E Herbison; G M Anderson; V Aucagne; M Beltramo
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

Review 8.  Pediatric Endocrinology in the Time of COVID-19: Considerations for the Rapid Implementation of Telemedicine and Management of Pediatric Endocrine Conditions.

Authors:  Molly O Regelmann; Rushika Conroy; Evgenia Gourgari; Anshu Gupta; Ines Guttmann-Bauman; Ryan Heksch; Manmohan K Kamboj; Sowmya Krishnan; Amit Lahoti; Kristal Matlock
Journal:  Horm Res Paediatr       Date:  2021-01-22       Impact factor: 2.852

9.  Using Kisspeptin to Predict Pubertal Outcomes for Youth With Pubertal Delay.

Authors:  Yee-Ming Chan; Margaret F Lippincott; Priscila Sales Barroso; Cielo Alleyn; Jill Brodsky; Hector Granados; Stephanie A Roberts; Courtney Sandler; Abhinash Srivatsa; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

10.  Delayed puberty in boys in central Sweden: an observational study on diagnosing and management in clinical practice.

Authors:  Maria Rodanaki; Eva Rask; Maria Lodefalk
Journal:  BMJ Open       Date:  2022-02-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.